There are 150 resources available
Entrectinib in NTRK fusion-positive gastrointestinal cancers: updated integrated analysis
Presenter: Ignacio Garrido-Laguna, United States
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
Introduction: The Statistics
Presenter: Erika Ruiz-Garcia, Mexico
Session: Session XX: Women for Oncology: The Construction of the Majority Minority
Resources:
Slides
Primary Liver Tumors
Presenter: Vincenzo Mazzaferro, Italy
Session: Session XXI: Surgical Advances in GI Oncology: Transplantation and Robotics
Resources:
Slides
Neoadjuvant immunotherapy in gastrointestinal tumors with mismatch repair deficiency: An institutional analysis
Presenter: Sakti Chakrabarti, United States
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
Female Voices: An Oncologist-Scientist Life
Presenter: Erika Ruiz-Garcia, Mexico; Sharlene Gill, Canada; Pia Osterlund, Finland; Deborah Mukherji, United Arab Emirates
Session: Session XX: Women for Oncology: The Construction of the Majority Minority
Discussant: SO-31, SO-32, SO-33
Presenter: Juan Manuel O'Connor, Argentina
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
Impact of BRAF-V600E mutation on immunologic characteristics of the tumor microenvironment (TME) and associated genomic alterations in patients with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) colorectal cancer (CRC)
Presenter: Mohamed Salem, United States
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
Liver Metastases in Colorectal Cancer
Presenter: René Adam, France
Session: Session XXI: Surgical Advances in GI Oncology: Transplantation and Robotics
Resources:
Slides
T-cell abundance measured by immunoSEQ predicts overall survival in colorectal cancer
Presenter: Stephen Gruber, United States
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
An immune-related gene expression profile predicts the efficacy of adding atezolizumab to first-line FOLFOXIRI/bevacizumab in metastatic colorectal cancer: a translational analysis of the phase II randomized AtezoTRIBE study
Presenter: Carlotta Antoniotti, Italy
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides